Publicaciones (36) Publicaciones de JOSÉ FERMÍN PÉREZ-REGADERA GÓMEZ

2023

  1. Taquicardia ventricular recurrente: informe de tres casos de radioablación cardíaca

    Revista de Física Médica, Vol. 24, Núm. 2, pp. 35-41

2022

  1. Experiencia inicial del tratamiento braquiterápico en coadyuvancia a la resección quirúrgica de cicatrices queloideas en población pediátrica

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica, Vol. 35, Núm. 4, pp. 207-211

  2. The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy

    Strahlentherapie und Onkologie, Vol. 198, Núm. 9, pp. 792-801

2021

  1. Impacto de la covid-19 en el tratamiento radioterápico del Hospital 12 de Octubre: nuestra experiencia

    Alfa, Núm. 46, pp. 51-52

  2. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group

    Gynecologic Oncology, Vol. 162, Núm. 2, pp. 407-412

2020

  1. A new and simple scoring system to predict overall survival after irradiation for metastatic spinal cord compression

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 440-444

  2. Implications of extraperitoneal paraaortic lymphadenectomy to the left renal vein in locally advanced cervical cancer. A Spanish multicenter study

    Gynecologic Oncology, Vol. 158, Núm. 2, pp. 287-293

  3. Prognostic Value and Therapeutic Implication of Laparoscopic Extraperitoneal Paraaortic Staging in Locally Advanced Cervical Cancer: A Spanish Multicenter Study

    Annals of Surgical Oncology, Vol. 27, Núm. 8, pp. 2829-2839

2019

  1. 18 F-FDG PET/CT in staging and delineation of radiotherapy volume for head and neck cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 3, pp. 154-159

  2. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

  3. Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites

    Reports of Practical Oncology and Radiotherapy, Vol. 24, Núm. 2, pp. 239-244

2018

  1. Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 402-410

2016

  1. Assessment of radiobiological metrics applied to patient-specific QA process of VMAT prostate treatments

    Journal of Applied Clinical Medical Physics, Vol. 17, Núm. 2, pp. 341-367

  2. Features of the area under the receiver operating characteristic (ROC) curve. A good practice

    Stata Journal, Vol. 16, Núm. 1, pp. 185-196

  3. Pathology-confirmed cerebral arterial invasion and recurrent multiple brain metastasis from cardiac myxoma without evidence of disease after surgery and radiotherapy

    Clinical Neuropathology

2012

  1. Consensus on treatment of endometrium carcinoma with brachytherapy

    Clinical and Translational Oncology, Vol. 14, Núm. 4, pp. 263-270

  2. Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: Long-term toxicity and esthetic assessment

    Clinical and Translational Oncology, Vol. 14, Núm. 12, pp. 953-960

  3. Early-stage breast cancer conservative treatment: High-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed

    Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 362-368

  4. Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study with 7-year follow-up

    International Journal of Radiation Oncology Biology Physics, Vol. 84, Núm. 5

2011

  1. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 34, Núm. 4, pp. 395-400